Sun Pharma, US-based Rockwell Medical enter into licensing pact for Triferic in India

"Sun Pharma....today announced that one of its wholly-owned subsidiaries has entered into exclusive licensing and supply agreements with Rockwell Medical Inc (Rockwell), to commercialise Rockwell#39;s Triferic, a proprietary iron replacement and haemoglobin maintenance drug, for treating anaemia in hemodialysis patients in India," the drug firm said in a regulatory filing.